Androgen deprivation therapy for prostate cancer
- 17 January 2008
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 9 (2) , 211-228
- https://doi.org/10.1517/14656566.9.2.211
Abstract
(2008). Androgen deprivation therapy for prostate cancer. Expert Opinion on Pharmacotherapy: Vol. 9, No. 2, pp. 211-228. doi: 10.1517/14656566.9.2.211Keywords
This publication has 146 references indexed in Scilit:
- Guideline for the Management of Clinically Localized Prostate Cancer: 2007 UpdateJournal of Urology, 2007
- Predictors of Overall and Cancer-Free Survival of Patients With Localized Prostate Cancer Treated With Primary Androgen Suppression Therapy: Results From the Prostate Cancer Outcomes StudyJournal of Urology, 2007
- Antiandrogens in the Treatment of Prostate CancerPublished by Elsevier ,2006
- Managing Complications of Androgen Deprivation Therapy for Prostate CancerUrologic Clinics of North America, 2006
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2005
- The Effects of Combined Androgen Blockade on Cognitive Function During the First Cycle of Intermittent Androgen Suppression in Patients With Prostate CancerJournal of Urology, 2003
- Fracture Risk Following Bilateral OrchiectomyJournal of Urology, 2003
- A Dominant-negative Mutant of Androgen Receptor Coregulator ARA54 Inhibits Androgen Receptor-mediated Prostate Cancer GrowthJournal of Biological Chemistry, 2002
- Alendronate for the Treatment of Osteoporosis in MenNew England Journal of Medicine, 2000
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999